93 related articles for article (PubMed ID: 1987262)
1. Ultrastructural localization of HTLV-I gag proteins p19 and p24 by single and double immunogold labeling.
Stransky G; Gay S
J Histochem Cytochem; 1991 Feb; 39(2):185-91. PubMed ID: 1987262
[TBL] [Abstract][Full Text] [Related]
2. Characterization of an antigen shared by human thymic epithelium and human T cell leukemia virus p19 Gag protein.
Palker TJ; Singer KH; Vahlne A
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jan; 11(1):10-9. PubMed ID: 8528727
[TBL] [Abstract][Full Text] [Related]
3. Differential antibody responsiveness to p19 gag results in serological discrimination between human T lymphotropic virus type I and type II.
Lal RB; Brodine SK; Coligan JE; Roberts CR
J Med Virol; 1991 Dec; 35(4):232-6. PubMed ID: 1687064
[TBL] [Abstract][Full Text] [Related]
4. Exposure of p19 matrix protein of human T-cell leukemia virus type I (HTLV-I) on the surface of MOLT-4#8 cells after virus adsorption.
Akari H; Kuroda MJ; Shinjo T; el-Farrash MA; Harada S
Arch Virol; 1994; 136(3-4):389-95. PubMed ID: 8031242
[TBL] [Abstract][Full Text] [Related]
5. HTLV-I and HTLV-II world-wide distribution: reanalysis of 4,832 immunoblot results.
Madeleine MM; Wiktor SZ; Goedert JJ; Manns A; Levine PH; Biggar RJ; Blattner WA
Int J Cancer; 1993 May; 54(2):255-60. PubMed ID: 8486428
[TBL] [Abstract][Full Text] [Related]
6. Morphological and antigenic variations of human T cell leukemia virus type I particles in human lymphocytes.
Miyauchi M; Maruyama K
J Electron Microsc (Tokyo); 1990; 39(3):145-54. PubMed ID: 2212921
[TBL] [Abstract][Full Text] [Related]
7. Human sera from varicella-zoster virus (VZV) infections cross-react with human T cell leukaemia virus type 1 (HTLV-1): common epitopes in VZV gene 22 protein and HTLV-1 p19 gag protein.
Sato A; Isaka Y; Morita F; Ishii A; Goto Y; Imai J; Igarashi H; Yoshie O; Hinuma Y
J Gen Virol; 1992 Nov; 73 ( Pt 11)():2969-73. PubMed ID: 1279104
[TBL] [Abstract][Full Text] [Related]
8. Production and characterization of a monoclonal antibody directed against HTLV-1 p19: use in a specific capture enzyme immunoassay.
Ebersold A; Noraz N; Grange J; Gasmi M; Grange MP; Souche S; Mamoun R; Desgranges C
Hybridoma; 1993 Apr; 12(2):185-95. PubMed ID: 7686136
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical localization of HTLV-I p19- and p24-related antigens in synovial joints of patients with rheumatoid arthritis.
Ziegler B; Gay RE; Huang GQ; Fassbender HG; Gay S
Am J Pathol; 1989 Jul; 135(1):1-5. PubMed ID: 2774054
[TBL] [Abstract][Full Text] [Related]
10. Expression of antigen reactive with a monoclonal antibody to HTLV-1 P19 in salivary glands in Sjögren's syndrome.
Shattles WG; Brookes SM; Venables PJ; Clark DA; Maini RN
Clin Exp Immunol; 1992 Jul; 89(1):46-51. PubMed ID: 1628425
[TBL] [Abstract][Full Text] [Related]
11. Antigenicity of chimeric synthetic peptides based on HTLV-1 antigens and the impact of epitope orientation.
Hernández M; Selles ME; Pozo Peña L; Gómez I; Melchor A
Biochem Biophys Res Commun; 2000 Oct; 276(3):1085-8. PubMed ID: 11027594
[TBL] [Abstract][Full Text] [Related]
12. Improvement of simultaneous detection of antibodies to Gag and envelope antigens of human T-lymphotropic virus type I by western immunoblot assay.
Miyakoshi H; Sugimoto M; Igarashi H; Honda H; Fujino R; Mizukoshi M
J Clin Microbiol; 1992 Oct; 30(10):2555-9. PubMed ID: 1400953
[TBL] [Abstract][Full Text] [Related]
13. Detection of p24 in HIV-1 infected cells embedded in LR White and Lowicryl K4M.
Stransky G; Garry RF; Gay S
Histochem J; 1991 Aug; 23(8):381-4. PubMed ID: 1917566
[TBL] [Abstract][Full Text] [Related]
14. Recognition of human T cell leukemia virus type I (HTLV-I) gag and pX gene products by MHC-restricted cytotoxic T lymphocytes induced in rats against syngeneic HTLV-I-infected cells.
Tanaka Y; Tozawa H; Koyanagi Y; Shida H
J Immunol; 1990 Jun; 144(11):4202-11. PubMed ID: 2187927
[TBL] [Abstract][Full Text] [Related]
15. Relationship between anti-Tax antibody responses and cocultivatable virus in HTLV-I-infected rabbits.
Lydy SL; Conner ME; Marriott SJ
Virology; 1998 Oct; 250(1):60-6. PubMed ID: 9770420
[TBL] [Abstract][Full Text] [Related]
16. Neutralizing activity of human antibodies against the structural protein of human T-cell lymphotropic virus type I.
Inoue Y; Kuroda N; Shiraki H; Sato H; Maeda Y
Int J Cancer; 1992 Dec; 52(6):877-80. PubMed ID: 1459728
[TBL] [Abstract][Full Text] [Related]
17. Role of the human T-cell leukemia virus type 1 PTAP motif in Gag targeting and particle release.
Dorweiler IJ; Ruone SJ; Wang H; Burry RW; Mansky LM
J Virol; 2006 Apr; 80(7):3634-43. PubMed ID: 16537631
[TBL] [Abstract][Full Text] [Related]
18. Involvement of p38 MAPK signaling pathway in IFN-gamma and HTLV-I expression in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
Fukushima N; Nishiura Y; Nakamura T; Yamada Y; Kohno S; Eguchi K
J Neuroimmunol; 2005 Feb; 159(1-2):196-202. PubMed ID: 15652420
[TBL] [Abstract][Full Text] [Related]
19. Long-term serological follow-up of blood donors with an HTLV-indeterminate western blot: antibody profile of seroconverters and individuals with false reactions.
Martins ML; Santos AC; Namen-Lopes MS; Barbosa-Stancioli EF; Utsch DG; Carneiro-Proietti AB
J Med Virol; 2010 Oct; 82(10):1746-53. PubMed ID: 20827773
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow derived cells express human T-cell lymphotropic virus type I (HTLV-I)-related antigens in patients with multiple sclerosis.
Sandberg-Wollheim M; Alumets J; Biörklund A; Gay R; Gay S
Scand J Immunol; 1988 Dec; 28(6):801-6. PubMed ID: 3068791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
